International Stem Cell CORP
ISCO· OTC
Released Mar 31, 2017, after the close
10-K filed Mar 31, 2017, 90 days after period end · 0001564590-17-005854
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.69M | $1.98M | $1.82M | $1.74M |
| Net Income | $2.16M | -$1.53M |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$4.60M |
| -$2.77M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.